Funding

Emmecell

United States · Biotech · Healthtech

Develops magnetic cell delivery technologies for treating corneal and other ophthalmic diseases

Visit emmecell.comFunding history

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
StrategicUndisclosedBausch + Lomb — Role not disclosed

Investors

Bausch + LombStrategic

Coverage

Jun 16, 2026Emmecell · Strategic

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesemmecell.com ↗